Company Profile
Ionis Pharmaceuticals, Inc. Stock Price, News & Analysis
- Ticker:
- IONS
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Carlsbad, California
Stock performance
52.95 USD (-27.44%)
Close
Last updated: July 20, 2026
12.1B USD
Market cap
Why the stock is moving
IONS is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Ionis Pharmaceuticals is an RNA-targeted medicines company focused on antisense technology and a broad pipeline of genetic and specialty-disease programs. Investors watch platform depth, partner execution, and the pace of new launches.
Geographic Base and Sector Classification
Headquartered in Carlsbad, California and listed on NASDAQ, Ionis is followed within the RNA therapeutics universe for its platform breadth and specialty-disease exposure.
Business Model Characteristics
Ionis combines platform licensing, partnered development, and commercial execution, so the market focuses on readouts, partnership value, and how quickly the pipeline can translate into revenue.
Position Within the Biotechnology Landscape
Compared with more mature peers, Ionis sits in a platform-heavy corner of the landscape, where RNA milestones can change the investment case quickly.
Future catalysts
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
- 02
Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA
BMY · Source: BMYBristol-Myers Squibb Company
- 03
- 04
Fresenius Medical Care introduces TherapyWise™ analytics for kidney replacement therapy
FMS · Source: Fresenius Medical Care Ventures
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Ionis Pharmaceuticals, Inc. (IONS)?
Ionis Pharmaceuticals, Inc. (IONS) most recently closed at 52.95 USD, a -27.44% move versus the previous session.
What is the market cap of Ionis Pharmaceuticals, Inc. (IONS)?
Ionis Pharmaceuticals, Inc. currently has a market capitalization of 12.1B USD on BioPharmSignal.
What does Ionis Pharmaceuticals, Inc. do?
Ionis Pharmaceuticals is an RNA-targeted medicines company focused on antisense technology and a broad pipeline of genetic and specialty-disease programs. Investors watch platform depth, partner execution, and the pace of new launches.
On which exchange is IONS stock listed?
Ionis Pharmaceuticals, Inc. (IONS) is associated with NASDAQ, Carlsbad, California, Biotechnology.
What is Ionis?
Ionis Pharmaceuticals is an RNA-targeted medicines company focused on antisense technology and a broad pipeline of genetic and specialty-disease programs.
Which conditions is Ionis Pharmaceuticals, Inc. targeting with Ionis?
Ionis Pharmaceuticals, Inc. is associated with genetic disease based on its company overview and current catalyst commentary.
What is Pharmaceuticals?
Ionis Pharmaceuticals is an RNA-targeted medicines company focused on antisense technology and a broad pipeline of genetic and specialty-disease programs.
What is RNA-targeted?
Ionis Pharmaceuticals is an RNA-targeted medicines company focused on antisense technology and a broad pipeline of genetic and specialty-disease programs.